| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018008703 | 2018-01-23 | ||
| PCT/JP2019/001969WO2019146612A1 (en) | 2018-01-23 | 2019-01-23 | Composition for skin diseases treatment use |
| Publication Number | Publication Date |
|---|---|
| SG11202007082PAtrue SG11202007082PA (en) | 2020-08-28 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202007082PASG11202007082PA (en) | 2018-01-23 | 2019-01-23 | Composition used for therapeutic treatment of skin disease |
| Country | Link |
|---|---|
| US (2) | US20200345783A1 (en) |
| EP (1) | EP3744347A4 (en) |
| JP (1) | JPWO2019146612A1 (en) |
| KR (1) | KR20200113225A (en) |
| CN (1) | CN112236168A (en) |
| AU (1) | AU2019211646A1 (en) |
| SG (1) | SG11202007082PA (en) |
| WO (1) | WO2019146612A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021147922A1 (en)* | 2020-01-20 | 2021-07-29 | 医微细胞生物技术(广州)有限公司 | Extracellular vesicle and use thereof in skin products |
| CN111297900B (en)* | 2020-05-13 | 2020-08-11 | 优赛生命科技有限公司 | Composition rich in adipose-derived stem cell exosomes and application thereof |
| KR102368442B1 (en)* | 2021-02-19 | 2022-02-28 | 주식회사 엑소코바이오 | Manufacturing method of exosome for enhancing its bioactivity and application thereof |
| CN114410576B (en)* | 2022-01-06 | 2025-03-07 | 上海市同济医院 | Application of adipose stem cell exosomes in hair growth |
| CN116808037A (en)* | 2023-07-06 | 2023-09-29 | 中国药科大学 | Use of Pitavastatin Calcium in the preparation of medicines for alleviating or treating allergic contact dermatitis |
| CN118319828B (en)* | 2024-04-17 | 2024-10-29 | 深圳市发道生物科技有限公司 | Hair-blacking and hair-growing composition and method of making same shampoo preparation and preparation method thereof |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5795352A (en) | 1980-11-29 | 1982-06-14 | Fumiko Matsuzaki | V shaped bias like knitting of hand knitted fabric |
| JPS6077909A (en) | 1983-10-03 | 1985-05-02 | Nippon Steel Corp | Process for opening and closing flow rate regulating valve |
| ES2532595T3 (en)* | 2006-08-30 | 2015-03-30 | Kyushu University, National University Corporation | Pharmaceutical composition containing an encapsulated statin nanoparticle |
| EP2488164B1 (en)* | 2009-10-15 | 2021-01-20 | The Brigham and Women's Hospital, Inc. | Release of agents from cells |
| EP2629782B1 (en)* | 2010-10-18 | 2019-02-20 | Agency For Science, Technology And Research | Use of exosomes derived from mesenchymal stem cells to promote or enhance hair growth |
| JP6159183B2 (en)* | 2013-07-23 | 2017-07-05 | 日本メナード化粧品株式会社 | Stem cell-derived growth factor production promoter |
| JP6110578B2 (en) | 2014-11-10 | 2017-04-05 | 学校法人大阪医科薬科大学 | Statin-encapsulating nanoparticle preparation for enhancing stem cell function, function-enhancing stem cell containing the same, and method for producing the same |
| JP6650240B2 (en)* | 2014-11-25 | 2020-02-19 | 花王株式会社 | Method of searching for melanin control agent |
| KR20200141501A (en)* | 2016-05-06 | 2020-12-18 | 각코우호징 오사카 이카야쿠카 다이가쿠 | Statin-containing nanoparticle preparation for enhancing function of stem cells for treating inflammatory disease and functionally enhanced stem cells containing same for treating inflammatory disease |
| JP6152205B1 (en) | 2016-08-09 | 2017-06-21 | 仁幸 小林 | Cosmetics, pharmaceutical compositions, and methods for producing them |
| CN108543074B (en)* | 2018-04-10 | 2021-06-11 | 华中科技大学 | Exosome-encapsulated nano drug delivery system for tumor treatment and preparation thereof |
| Publication number | Publication date |
|---|---|
| CN112236168A (en) | 2021-01-15 |
| US20240180971A1 (en) | 2024-06-06 |
| US20200345783A1 (en) | 2020-11-05 |
| WO2019146612A1 (en) | 2019-08-01 |
| JPWO2019146612A1 (en) | 2020-11-26 |
| AU2019211646A1 (en) | 2020-08-06 |
| KR20200113225A (en) | 2020-10-06 |
| EP3744347A4 (en) | 2021-12-01 |
| EP3744347A1 (en) | 2020-12-02 |
| Publication | Publication Date | Title |
|---|---|---|
| IL275754A (en) | Compounds, compositions, and methods for treatment of diseases involving acidic or hypoxic diseased tissues | |
| IL276383A (en) | Treatment of ophthalmologic diseases | |
| SG11202007082PA (en) | Composition used for therapeutic treatment of skin disease | |
| PT3377637T (en) | Compositions and methods for the treatment of wounds, disorders, and diseases of the skin | |
| IL279397A (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of diseases | |
| IL278041A (en) | Buffered formulations of bevacizumab for use of treating diseases | |
| IL289405A (en) | Personalized treatment of ophthalmologic diseases | |
| IL282643A (en) | Combination therapy for treatment of hematological diseases | |
| IL274578A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| EP3685840A4 (en) | COMPOSITE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INFLAMMABLE SKIN DISEASES | |
| GB201805100D0 (en) | Treatment of sarcopenic diseases | |
| IL257229A (en) | Blood applicator for tissue treatment | |
| SG11202001595SA (en) | Angio-3 for treatment of retinal angiogenic diseases | |
| IL272495A (en) | Compounds and pharmaceutical compositions thereof for use in the treatment of fibrotic diseases | |
| ZA202002075B (en) | Compounds, compositions and methods for treatment of eye disorders and skin diseases | |
| PL3852663T3 (en) | Device for treatment of body tissue | |
| EP3569249A4 (en) | MEDICAL COMPOSITION FOR TREATMENT OF CONTINUOUS HEART DISEASE | |
| KR20180085033A (en) | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF SKIN DISEASES | |
| IL247369A0 (en) | Compositions and methods for treatment of bone associated diseases | |
| GB201909438D0 (en) | Treatment of diseases | |
| GB201811912D0 (en) | Treatment of disease | |
| GB201811911D0 (en) | Treatment of disease | |
| GB201810974D0 (en) | Treatment of disease | |
| ZA201904327B (en) | Treatment of skin conditions | |
| HK40015373A (en) | Phosphaplatin compounds as therapeutic agents for treatment of bone blood cancers |